Study Reveals Low Recurrence Rates of Breast Cancer in Young Women

Recent research has indicated that young women under the age of 40 diagnosed with breast cancer experience low rates of isolated locoregional recurrence (LRR). This finding is based on a study published in JAMA Surgery, which analyzed data from a multicenter prospective cohort.

Researchers from Brigham and Women's Hospital in Boston conducted a detailed examination of long-term LRR incidence categorized by molecular subtype. The study encompassed 1,135 women diagnosed with stage I to III breast cancer between 2006 and 2016, with a median follow-up period of 10.1 years. Among the participants, 12.8% were diagnosed before the age of 30, 28.0% between 31 and 35, and 59.2% were between 36 and 40 years old.

Throughout the study, 59 isolated local recurrences and four isolated regional recurrences were identified, translating to rates of 5.2% and 0.4%, respectively. The cumulative incidence of LRR after 10.1 years varied by molecular subtype, with rates of 4.4%, 4.7%, 6.1%, 2.2%, and 6.5% for luminal A, luminal B, luminal ERBB2+, ERBB2+, and triple-negative subtypes.

When examining locoregional treatment types, the cumulative incidence rates were recorded at 6.7% for breast-conserving therapy, 6.5% for mastectomy without radiation, and 2.4% for mastectomy with radiation. Notably, a multivariable analysis revealed that mastectomy combined with radiation therapy was associated with the lowest risk of LRR, although no significant differences were observed across the various molecular subtypes.

The authors of the study expressed that the overall low rates of isolated LRR in this extensive contemporary cohort provide reassurance for young women diagnosed with breast cancer. They emphasized the necessity for longer-term follow-up to better understand future LRR risks given the increasing number of young women receiving breast cancer diagnoses.

Several authors associated with the study have declared relationships with the biopharmaceutical industry, highlighting the importance of transparency in research.

For further details, refer to the study titled 'Long-Term Locoregional Outcomes in a Contemporary Cohort of Young Women With Breast Cancer' published in JAMA Surgery.